tiprankstipranks
Ehealth (CH:M5V)
NASDAQ:M5V
Switzerland Market

Ehealth (M5V) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

M5V Analyst Ratings

Hold
5Ratings
Hold
0 Buy
5 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Ehealth
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

M5V Stock 12 Month Forecast

Average Price Target

$2.16
Based on 5 Wall Street analysts offering 12 month price targets for Ehealth in the last 3 months. The average price target is $2.16 with a high forecast of $2.43 and a low forecast of $1.62. The average price target represents a change from the last price of .
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
Highest Price Target$2.43Average Price Target$2.16Lowest Price Target$1.62
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CH:M5V
Craig-Hallum
Craig-Hallum
Hold
Reiterated
06/08/26
Analysts Offer Insights on Financial Companies: Ehealth (NASDAQ: EHTH) and Merlin (NASDAQ: MRLN)
RBC Capital Analyst forecast on CH:M5V
RBC Capital
RBC Capital
CHF2.43
Hold
Reiterated
05/14/26
Analysts Offer Insights on Financial Companies: Ehealth (NASDAQ: EHTH), Robinhood (NASDAQ: HOOD) and Charles Schwab (NYSE: SCHW)
Deutsche Bank  Analyst forecast on CH:M5V
Deutsche Bank
Deutsche Bank
CHF1.62CHF2.43
Hold
Reiterated
05/08/26
eHealth price target raised to $3 from $2 at Deutsche BankeHealth price target raised to $3 from $2 at Deutsche Bank
UBS
CHF1.62
Hold
Reiterated
05/07/26
UBS Sticks to Its Hold Rating for Ehealth (EHTH)
William Blair Analyst forecast on CH:M5V
William Blair
William Blair
Hold
Reiterated
05/07/26
Analysts Are Neutral on These Financial Stocks: Aurora Acquisition (BETR), Ehealth (EHTH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Craig-Hallum Analyst forecast on CH:M5V
Craig-Hallum
Craig-Hallum
Hold
Reiterated
06/08/26
Analysts Offer Insights on Financial Companies: Ehealth (NASDAQ: EHTH) and Merlin (NASDAQ: MRLN)
RBC Capital Analyst forecast on CH:M5V
RBC Capital
RBC Capital
CHF2.43
Hold
Reiterated
05/14/26
Analysts Offer Insights on Financial Companies: Ehealth (NASDAQ: EHTH), Robinhood (NASDAQ: HOOD) and Charles Schwab (NYSE: SCHW)
Deutsche Bank  Analyst forecast on CH:M5V
Deutsche Bank
Deutsche Bank
CHF1.62CHF2.43
Hold
Reiterated
05/08/26
eHealth price target raised to $3 from $2 at Deutsche BankeHealth price target raised to $3 from $2 at Deutsche Bank
UBS
CHF1.62
Hold
Reiterated
05/07/26
UBS Sticks to Its Hold Rating for Ehealth (EHTH)
William Blair Analyst forecast on CH:M5V
William Blair
William Blair
Hold
Reiterated
05/07/26
Analysts Are Neutral on These Financial Stocks: Aurora Acquisition (BETR), Ehealth (EHTH)
Stocks with the Highest Top Analyst Consensus in the Financial Sector
FAFFirst American Financial
BANCBanc of California
WULFTeraWulf Inc
SPGIS&P Global
BPOPPopular
Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

M5V Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
0
0
0
0
Buy
1
0
0
0
0
Hold
5
6
8
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
6
8
7
6
In the current month, M5V has received 0 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. M5V average Analyst price target in the past 3 months is 2.16.
Each month's total comprises the sum of three months' worth of ratings.

M5V Financial Forecast

M5V Earnings Forecast

Next quarter’s earnings estimate for M5V is -$0.68 with a range of -$1.00 to -$0.42. The previous quarter’s EPS was -$0.25. M5V beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year M5V has Performed in-line its overall industry.
Next quarter’s earnings estimate for M5V is -$0.68 with a range of -$1.00 to -$0.42. The previous quarter’s EPS was -$0.25. M5V beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 65.60% of the time in the same period. In the last calendar year M5V has Performed in-line its overall industry.

M5V Sales Forecast

Next quarter’s sales forecast for M5V is $26.97M with a range of $23.40M to $28.66M. The previous quarter’s sales results were $71.32M. M5V beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year M5V has Performed in-line its overall industry.
Next quarter’s sales forecast for M5V is $26.97M with a range of $23.40M to $28.66M. The previous quarter’s sales results were $71.32M. M5V beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 79.60% of the time in the same period. In the last calendar year M5V has Performed in-line its overall industry.

M5V Stock Forecast FAQ

What is CH:M5V’s average 12-month price target, according to analysts?
Based on analyst ratings, Ehealth’s 12-month average price target is 2.16.
    What is CH:M5V’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:M5V, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Ehealth a Buy, Sell or Hold?
        Ehealth has a consensus rating of Hold, which is based on 0 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Ehealth’s share price target?
          The average share price target for Ehealth is 2.16. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $2.43 ,and the lowest forecast is $1.62. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Ehealth?
            Ehealth’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of Ehealth?
              To buy shares of CH:M5V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.